Market closed

Prestige Consumer Healthcare/$PBH

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Prestige Consumer Healthcare

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Ticker

$PBH

Trading on

NYSE

Industry

Pharmaceuticals

Employees

570

PBH Metrics

BasicAdvanced
$4.1B
Market cap
20.16
P/E ratio
$4.10
EPS
0.47
Beta
-
Dividend rate
$4.1B
0.47
$82.04
$56.61
279K
3.561
2.012
61.107
61.26
5.68%
6.12%
12.61%
20.163
3.705
2.36
-3.67
16.161
-1.45%
-348.47%
2.81%
5.01%

What the Analysts think about PBH

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Prestige Consumer Healthcare stock.

PBH Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

PBH Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PBH

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Prestige Consumer Healthcare stock?

Prestige Consumer Healthcare (PBH) has a market cap of $4.1B as of November 22, 2024.

What is the P/E ratio for Prestige Consumer Healthcare stock?

The price to earnings (P/E) ratio for Prestige Consumer Healthcare (PBH) stock is 20.16 as of November 22, 2024.

Does Prestige Consumer Healthcare stock pay dividends?

No, Prestige Consumer Healthcare (PBH) stock does not pay dividends to its shareholders as of November 22, 2024.

When is the next Prestige Consumer Healthcare dividend payment date?

Prestige Consumer Healthcare (PBH) stock does not pay dividends to its shareholders.

What is the beta indicator for Prestige Consumer Healthcare?

Prestige Consumer Healthcare (PBH) has a beta rating of 0.47. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.